Check-Cap Ltd. (7CC)
XSTU
Real-time Data
06:00 AM
Day's Range
6.7552 wk Range
3.67Overview - 7CC - Check-Cap Ltd.
Key Statistics
Valuation
Enterprise Value
14.00K
P/E (Trailing)
‪10.30‬
EV / EBITDA
‪-0.0064‬
Profitability
Return on Assets
‪55.30%‬
Return on Equity
‪120.45%‬
Ownership
Shares Outstanding
7.02M
Price stats
50-Day Avg
‪7.19‬
200-Day Avg
‪9.22‬
Peers - 7CC - Check-Cap Ltd.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XSTU.
- 7CCXSTUCheck-Cap Ltd.+48.78%52-week change1.86P/E (Trailing)—Profit Margin
- NL0XSTUGrail, Inc.+58.79%52-week change-6.25P/E (Trailing)‪-236.94%‬Profit Margin
- 8YYXSTUCoro Energy plc+86.30%52-week change0.07P/E (Trailing)‪63.04%‬Profit Margin
- 0MEXSTUTwist Bioscience Corporation+80.50%52-week change-92.62P/E (Trailing)‪50.72%‬Profit Margin
- ILUXSTUIllumina, Inc.+55.45%52-week change34.79P/E (Trailing)‪66.08%‬Profit Margin
- 12VXSTUVeracyte Inc.+49.99%52-week change54.75P/E (Trailing)‪70.10%‬Profit Margin
- WX8XSTUWuXi AppTec Co., Ltd.+46.51%52-week change2.46P/E (Trailing)‪47.63%‬Profit Margin
Profile Summary - 7CC - Check-Cap Ltd.
About
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Israel, specializing in the development of innovative capsule-based screening technology for colorectal cancer detection. Founded in 2004, the company focuses on its proprietary C-Scan system, which includes an ingestible capsule that uses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
